Risk-Adapted Therapy With Three or Six Cycles of Doxorubicin/Bleomycin/Vinblastine/Dacarbazine Plus Involved-Field Radiation Therapy in Hodgkin Lymphoma, Based on Prognosis at Diagnosis and Early Response: Results From the GATLA Study

Authors:
  • CCClaudia Corrado
    Claudia Corrado
  • MPMiguel A. Pavlovsky
    Miguel A. Pavlovsky
  • MPMaría V. Prates
    María V. Prates
  • LZLucía Zoppegno
    Lucía Zoppegno
  • MGMario Giunta
    Mario Giunta
  • ICIder Cerutti
    Ider Cerutti
  • EPElsa Palomino
    Elsa Palomino
  • FPFernando Pagani
    Fernando Pagani
  • FLFrancisco Lastiri
    Francisco Lastiri
  • DBDaniel Bar
    Daniel Bar
  • RBRaimundo F. Bezares
    Raimundo F. Bezares

Abstract
No abstract available

This publication has 21 references indexed in Scilit: